Evidence map›Paper›PMID 32793230›Full record

ReviewFrontiers in immunology2020

The Heterogeneity, Origins, and Impact of Migratory iILC2 Cells in Anti-helminth Immunity.

Mindy M Miller, R Lee Reinhardt

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. ILC2s and their immune checkpoints in the antitumor response.Journal for immunotherapy of cancer · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Critical and diverse role of alarmin cytokines in parasitic infections.Frontiers in cellular and infection microbiology · 2024
    Review
  8. Article
  9. Article
  10. Examination of Horizontal Transmission ofJournal of the American Association for Laboratory Animal Science : JAALAS · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mindy M MillerDepartment of Biomedical Research, National Jewish Health, Denver, CO, United States.
R Lee ReinhardtDepartment of Biomedical Research, National Jewish Health, Denver, CO, United States.
University of Colorado Denver · US

Funding

The Role of BATF in Allergic Inflammation and Anti-Helminth ImmunityR01AI119004 · NIAID · NATIONAL JEWISH HEALTH · PI REINHARDT, RICHARD LEE · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI119004
6 · The paper itself

Abstract

Soil-transmitted helminths represent a major global health burden with infections and infection-related comorbidities causing significant reductions in the quality of life for individuals living in endemic areas. Repeated infections and chronic colonization by these large extracellular worms in mammals led to the evolution of type-2 immunity characterized by the production of the type-2 cytokines interleukin (IL)-4, IL-5, and IL-13. Although a number of adaptive and innate immune cells produce type-2 cytokines, a key cellular source in the context of helminth infection is group 2 innate lymphoid cells (ILC2s). ILC2s promote mucosal barrier homeostasis, integrity, and repair by rapidly responding to epithelial cues in mucosal tissues. Though tissue-resident ILC2s (nILC2s) have been studied in detail over the last decade, considerably less is known with regard to a subset of inflammatory ILC2s (iILC2s) that migrate to the lungs of mice early after

Indexed as

AnimalsCytokinesGlobal HealthHelminthiasisHelminthsInflammationLymphocytesLymphocyte SubsetsNippostrongylusCytokineshelminthiILC2IL-13IL-4ILC2nILC2Nippostrongylus brasiliensistype-2 immunity

Identifiers

PMID32793230
PMCPMC7390839
OpenAlexW3037301125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.